---
figid: PMC4531138__18_2015_1925_Fig2_HTML
figtitle: miRNAs control inflammatory response in ECs
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC4531138
filename: 18_2015_1925_Fig2_HTML.jpg
figlink: /pmc/articles/PMC4531138/figure/Fig2/
number: F2
caption: miRNAs control inflammatory response in ECs. miRNAs control the expression
  of inflammatory chemokines such as CCL2 and CXCL1 predominantly indirectly by regulating
  the expression of signaling molecules of the NF-κB signaling pathway. For instance,
  miR-181b inhibits the NF-κB-mediated CXCL1 expression by suppressing the expression
  of importin-α3, which is required for the nuclear translocation of NF-κB. miR-103
  and miR-92a targets the NF-κB inhibitor KLF4, thereby increasing CCL2 and CXCL1
  expression in ECs. In contrast, miR-21 reduces CCL2 expression by blocking the AP-1
  signaling pathway. A direct regulation of CCL2 is reported for miR-495, which induces
  CCL2 mRNA degradation by binding to its response element in the 3′ UTR. Moreover,
  miR-126-3p controls the expression of CXCL12, directly and indirectly via its target
  RGS16. NF-κB nuclear factor-κB, CCL2 chemokine (CC motif) ligand 2, CXCL1 chemokine
  (CXC motif) ligand 1, CXCL12 chemokine (CXC motif) ligand 12, CXCR4 chemokine (CXC
  motif) receptor 4, KLF2/4 Krüppel-like factor 2/4, SOCS1 suppressor of cytokine
  signaling 1, β‐TRC β‐transducin repeat‐containing gene, TAK1 transforming growth
  factor β-activated kinase 1, TRAF6 TNF receptor-associated factor 6, IRAK1 interleukin-1
  receptor-associated kinase 1/2, RGS16 regulator of G-protein signaling 16, SIRT1
  sirtuin-1, THBS1 thrombospondin 1, TGFBR1 transforming growth factor, beta receptor
  1, SMAD2 SMAD family member 2, PPARα peroxisome proliferator-activated receptor
  α, AP-1 activator-protein 1. The dashed arrow indicates an indirect regulation
papertitle: Chemokines and microRNAs in atherosclerosis.
reftext: Petra Hartmann, et al. Cell Mol Life Sci. 2015;72(17):3253-3266.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9621747
figid_alias: PMC4531138__F2
figtype: Figure
redirect_from: /figures/PMC4531138__F2
ndex: c106f342-debb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4531138__18_2015_1925_Fig2_HTML.html
  '@type': Dataset
  description: miRNAs control inflammatory response in ECs. miRNAs control the expression
    of inflammatory chemokines such as CCL2 and CXCL1 predominantly indirectly by
    regulating the expression of signaling molecules of the NF-κB signaling pathway.
    For instance, miR-181b inhibits the NF-κB-mediated CXCL1 expression by suppressing
    the expression of importin-α3, which is required for the nuclear translocation
    of NF-κB. miR-103 and miR-92a targets the NF-κB inhibitor KLF4, thereby increasing
    CCL2 and CXCL1 expression in ECs. In contrast, miR-21 reduces CCL2 expression
    by blocking the AP-1 signaling pathway. A direct regulation of CCL2 is reported
    for miR-495, which induces CCL2 mRNA degradation by binding to its response element
    in the 3′ UTR. Moreover, miR-126-3p controls the expression of CXCL12, directly
    and indirectly via its target RGS16. NF-κB nuclear factor-κB, CCL2 chemokine (CC
    motif) ligand 2, CXCL1 chemokine (CXC motif) ligand 1, CXCL12 chemokine (CXC motif)
    ligand 12, CXCR4 chemokine (CXC motif) receptor 4, KLF2/4 Krüppel-like factor
    2/4, SOCS1 suppressor of cytokine signaling 1, β‐TRC β‐transducin repeat‐containing
    gene, TAK1 transforming growth factor β-activated kinase 1, TRAF6 TNF receptor-associated
    factor 6, IRAK1 interleukin-1 receptor-associated kinase 1/2, RGS16 regulator
    of G-protein signaling 16, SIRT1 sirtuin-1, THBS1 thrombospondin 1, TGFBR1 transforming
    growth factor, beta receptor 1, SMAD2 SMAD family member 2, PPARα peroxisome proliferator-activated
    receptor α, AP-1 activator-protein 1. The dashed arrow indicates an indirect regulation
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mir10a
  - Mirlet7g
  - Mir34a
  - Cish
  - Klf2
  - Nr2c2
  - Map3k7
  - Btrc
  - Klf4
  - Mir146
  - Elavl1
  - Mir21a
  - Sirt1
  - Thbs1
  - Traf6
  - Irak1
  - Rgs16
  - Gde1
  - Tgfbr1
  - Nfkb1
  - Ppara
  - Mir495
  - Mir155
  - Smad2
  - Cxcr4
  - Cxcl12
  - Ets1
  - Cxcl1
  - Ccl2
  - Mir221
  - Mir222
  - Jun
  - MIR10A
  - MIRLET7G
  - MIR34A
  - CISH
  - KLF2
  - MAP3K7
  - NR2C2
  - BTRC
  - KLF4
  - ELAVL1
  - MIR21
  - SIRT1
  - THBS1
  - TRAF6
  - IRAK1
  - RGS16
  - TGFBR1
  - NFKB1
  - PPARA
  - MIR495
  - MIR155
  - SMAD2
  - CXCR4
  - CXCL12
  - ETS1
  - CXCL1
  - CCL2
  - MIR221
  - MIR222
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - dre-mir-103
  - mir10a
  - mir34a
  - klf4
  - klf17
  - sirt1
  - thbs1b
  - traf6
  - irak1
  - rgs16
  - tgfbr1a
  - pparab
  - mir155
  - smad2
  - cxcr4b
  - cxcl12a
  - ets1
  - ccl38a.5
  - dre-mir-221
  - dre-mir-222
---
